Anika Therapeutics
ANIK
111 hedge funds and large institutions have $197M invested in Anika Therapeutics in 2013 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 25 reducing their positions, and 3 closing their positions.
14,300% more call options, than puts
Call options by funds: $3.74M | Put options by funds: $26K
700% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 25
72% more capital invested
Capital invested by funds: $114M → $197M (+$82.9M)
23% more funds holding
Funds holding: 90 → 111 (+21)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$5.41M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$3.49M |
| 3 |
PA
Perceptive Advisors
New York
|
+$3.23M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$3M |
| 5 |
Morgan Stanley
New York
|
+$2.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.71M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
-$1.87M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$1.46M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$1.07M |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$940K |
ANIK Hedge Fund Activity: Q3 2013 in Review
111 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q3 2013, worth a combined $197M — up 72% from $114M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ANIK positions and 3 closed out — a net gain of 21 holders — while 50 added to existing stakes and 25 trimmed.
The largest buyer was Numeric Investors, adding an estimated $5.41M. The largest seller was Wellington Management Group, cutting an estimated $7.71M.
- 111 institutional investors held Anika Therapeutics (ANIK) as of Q3 2013, up from 90 in Q2 2013.
- Funds reported $197M of Anika Therapeutics stock for Q3 2013, up 72% quarter-over-quarter.
- 24 funds opened new Anika Therapeutics positions in Q3 2013 and 3 closed out, a net change of +21 holders.
- The largest Anika Therapeutics buyer in Q3 2013 was Numeric Investors, an estimated $5.41M added.
- The largest Anika Therapeutics seller in Q3 2013 was Wellington Management Group, an estimated $7.71M sold.
Based on aggregated 13F filings for Q3 2013.